The study analyzed data from 12,772 participants across Brazil, with an average age of 52 at the time of enrollment. Over an average follow-up period of eight years, researchers meticulously tracked the intake of seven specific sweeteners: aspartame, saccharin, acesulfame K, erythritol, xylitol, sorbitol, and tagatose. These substances are ubiquitous in the global food supply, appearing in everything from diet sodas and flavored waters to "fit" yogurts, sugar-free desserts, and even certain medications. The findings indicate that those in the highest tier of sweetener consumption experienced cognitive decline at a rate significantly faster than those who consumed the least, raising questions about the safety profile of these ingredients for long-term brain maintenance.
Study Design and Methodology
To establish a clear picture of the relationship between sweetener intake and brain health, the researchers utilized the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). At the beginning of the observation period, participants provided exhaustive dietary information through validated food frequency questionnaires. This allowed the research team to quantify the daily intake of various sweeteners in milligrams. Based on this data, the cohort was divided into three distinct groups: low, medium, and high consumption.
The "low" consumption group averaged just 20 milligrams per day (mg/day), whereas the "high" group averaged 191 mg/day. To put these numbers into a practical context, the researchers noted that the aspartame intake in the high-consumption group was roughly equivalent to the amount found in a single 12-ounce can of diet soda. This suggests that even "moderate" habitual use by modern standards could place an individual in the highest risk category identified by the study. Among the individual sweeteners, sorbitol was the most heavily consumed, with an average daily intake of 64 mg/day across the study population.
Cognitive health was measured at three intervals—the start, the midpoint, and the conclusion of the eight-year period. The assessment battery was designed to test multiple domains of brain function, including verbal fluency (the ability to retrieve words quickly), working memory (the short-term retention and manipulation of information), and processing speed (the efficiency with which the brain responds to stimuli). By using a multi-year timeline, the researchers were able to calculate the trajectory of decline for each participant rather than relying on a single snapshot of mental performance.
Quantifying the Cognitive Decline
The results revealed a stark disparity between the consumption groups. After adjusting for various confounding factors—including age, biological sex, education level, smoking status, physical activity, and pre-existing conditions like hypertension or cardiovascular disease—the researchers found that the high-consumption group experienced a 62% faster decline in overall cognitive performance compared to the low-consumption group.
To make these statistics more relatable to clinical practice and public health, the researchers translated the percentage of decline into "years of brain aging." The 62% faster decline observed in the high-intake group was estimated to be equivalent to approximately 1.6 additional years of cognitive aging over the eight-year study period. Even those in the middle consumption group were not immune; they experienced a 35% faster decline than the lowest group, equivalent to roughly 1.3 years of additional brain aging.
The researchers also noted that the association was not uniform across all age groups. Interestingly, the link between high sweetener intake and faster decline was most pronounced in participants under the age of 60. In this younger demographic, higher consumption was specifically tied to worse outcomes in verbal fluency and global cognition. Conversely, the association was less statistically significant among participants older than 60, suggesting that middle age may be a critical window during which dietary habits exert a more profound influence on future neurological outcomes.
The Role of Diabetes and Metabolic Health
One of the most significant findings of the study was the heightened risk observed among individuals with diabetes. The association between sweetener intake and cognitive decline was notably stronger in this population. This is particularly concerning because people with diabetes or pre-diabetes are the primary demographic encouraged to switch from sugar to artificial sweeteners to manage blood glucose levels.
"People with diabetes are more likely to use artificial sweeteners as sugar substitutes because they are often advised to limit products that rapidly raise blood sugar," explained Dr. Suemoto. However, the study suggests that this substitution might come with a hidden neurological cost. While sugar substitutes may help manage glycemic load, they may simultaneously interact with metabolic or inflammatory pathways that affect the brain. The researchers emphasized that for this group, the quest for a "safe" sweetener remains ongoing, as the study’s results suggest that current synthetic and sugar-alcohol options may not be the inert substances they were once thought to be.
Analyzing Individual Sweeteners
The study went beyond total intake to look at the specific types of sweeteners being used. Of the seven substances examined, six were independently linked to faster declines in cognitive function, particularly memory:
- Aspartame: One of the most studied and controversial sweeteners, commonly found in diet sodas and "blue" tabletop packets.
- Saccharin: The oldest artificial sweetener, often found in "pink" packets.
- Acesulfame K: Frequently used in combination with other sweeteners to mask bitter aftertastes in sodas and protein shakes.
- Erythritol: A sugar alcohol that has gained massive popularity in "keto" and low-carb products.
- Sorbitol: Often used in sugar-free gums and candies due to its cooling sensation and bulk.
- Xylitol: A sugar alcohol common in dental products and sugar-free baked goods.
The only sweetener included in the study that did not show a correlation with cognitive decline was tagatose. Tagatose is a "rare sugar" that is chemically similar to fructose but is metabolized differently, resulting in a lower glycemic index. While the reason for its neutrality in this study is not yet fully understood, its different metabolic pathway may play a role.
Broader Context and Scientific Hypotheses
This study adds to a growing body of evidence questioning the long-term health impacts of non-sugar sweeteners (NSS). In 2023, the World Health Organization (WHO) issued a guideline recommending against the use of NSS to control body weight or reduce the risk of non-communicable diseases. The WHO noted that while these sweeteners may provide short-term weight loss, they do not offer long-term benefits and may increase the risk of type 2 diabetes and cardiovascular diseases.
While the Neurology study was observational and cannot prove that sweeteners cause brain decline, several biological mechanisms have been proposed by the scientific community. One theory involves the gut-brain axis. Many sweeteners, particularly sugar alcohols like erythritol and sorbitol, are known to alter the composition of the gut microbiome. A dysbiotic gut can lead to systemic inflammation, which is a known driver of neurodegeneration.
Another hypothesis suggests that artificial sweeteners may interfere with the brain’s "reward" system. Because these substances provide an intense sweet taste without the expected caloric load, they may disrupt metabolic signaling, leading to insulin resistance—even in the absence of high blood sugar. Insulin resistance in the brain, sometimes referred to as "Type 3 diabetes," is a major risk factor for Alzheimer’s disease and other forms of dementia.
Industry and Public Health Implications
The findings pose a significant challenge to the food and beverage industry, which has spent decades reformulating products to reduce sugar content in response to the global obesity epidemic. If the very tools used to reduce sugar are themselves linked to cognitive impairment, public health officials may need to rethink dietary guidelines.
Consumer advocacy groups have already begun calling for clearer labeling of ultra-processed foods (UPFs) that contain these sweeteners. Since many consumers choose "diet" or "zero" products under the impression that they are making a healthier choice, there is a growing demand for transparency regarding the potential long-term neurological risks.
Dr. Suemoto and her team suggest that instead of reaching for synthetic substitutes, consumers and healthcare providers should look toward whole-food alternatives. "More research is needed to investigate if other refined sugar alternatives, such as applesauce, honey, maple syrup, or coconut sugar, may be effective alternatives," Suemoto noted, though she cautioned that these still contain calories and must be used in moderation.
Limitations and Future Directions
Despite the large sample size and long duration, the study has limitations that warrant caution. The reliance on self-reported dietary data is a common hurdle in nutritional science, as participants may underreport consumption or fail to remember specific ingredients in processed foods. Furthermore, as an observational study, it cannot account for every possible lifestyle factor that might influence cognitive health.
The researchers also pointed out that their study did not cover every sweetener on the market. Newer alternatives like stevia or monk fruit were not part of this specific analysis, meaning the results cannot be generalized to all sugar substitutes.
Moving forward, the medical community is calling for randomized controlled trials and mechanistic studies to determine exactly how these chemicals interact with neural tissues. For now, the findings published in Neurology serve as a cautionary note for the millions of people who rely on sugar substitutes daily. The data suggests that when it comes to brain health, the "sweetness" of a calorie-free diet may come at a much higher price than previously imagined.
